Vimarsana
Biggest News Aggregation in the World

Page 22 - Diagnostics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Diagnostics Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Diagnostics Inc Today - Breaking & Trending Today

Key Players in India's Emerging Infectious Disease - Vimarsana News

Key Players in India's Emerging Infectious Disease

Dublin, Nov. 09, 2023 (GLOBE NEWSWIRE) -- The

Accelerate Diagnostics (NASDAQ:AXDX) Upgraded by StockNews.com to Hold - Vimarsana News

Accelerate Diagnostics (NASDAQ:AXDX) Upgraded by StockNews.com to Hold

StockNews.com upgraded shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) from a sell rating to a hold rating in a research report report published on Sunday morning. Accelerate Diagnostics Stock Up 0.5 % Accelerate Diagnostics stock opened at $5.76 on Friday. Accelerate Diagnostics has a 52 week low of $4.50 and a 52 week high […]

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results - Vimarsana News

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Receives grant award from the Bill & Melinda Gates Foundation in the amount of $9.0M for the development of tuberculosis test on Co-Dx™ PCR platfo...

Accelerate Diagnostics (NASDAQ:AXDX) Raised to Hold at StockNews.com - Vimarsana News

Accelerate Diagnostics (NASDAQ:AXDX) Raised to Hold at StockNews.com

StockNews.com upgraded shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) from a sell rating to a hold rating in a report released on Sunday. Accelerate Diagnostics Price Performance AXDX opened at $5.73 on Friday. The firm has a market cap of $82.34 million, a price-to-earnings ratio of -0.79 and a beta of 1.08. Accelerate Diagnostics […]

Accelerate Diagnostics (NASDAQ:AXDX) Stock Rating Upgraded by StockNews.com - Vimarsana News

Accelerate Diagnostics (NASDAQ:AXDX) Stock Rating Upgraded by StockNews.com

StockNews.com upgraded shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) from a sell rating to a hold rating in a report issued on Sunday. Accelerate Diagnostics Trading Up 1.1 % NASDAQ AXDX opened at $5.73 on Friday. The stock has a market capitalization of $82.34 million, a price-to-earnings ratio of -0.79 and a beta of […]

Source: wkrb13.com